iloperidone 8 MG Oral Tablet

RxCUI: 848748
RxNorm name: iloperidone 8 MG Oral Tablet
Display name: iloperidone 8 MG Oral Tablet
Full name: iloperidone 8 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
FANAPT	ILOPERIDONE	Vanda Pharmaceuticals Inc.	33f60b40-3fca-11de-8f56-0002a5d5c51b	2026-05-06	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 848748
ILOPERIDONE	ILOPERIDONE	Mylan Pharmaceuticals Inc.	eeb0fcfd-e4e8-4fb1-9635-901dc9446235	2025-03-13	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 848748

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
33f60b40-3fca-11de-8f56-0002a5d5c51b	iloperidone 8 MG Oral Tablet [PSN] · iloperidone 8 MG Oral Tablet [SCD]	2	35	These highlights do not include all the information needed to use FANAPT safely and effectively. See full prescribing information for FANAPT. FANAPT ® (iloperidone) tablets, for oral use Initial U.S. Approval: 2009	20260506
eeb0fcfd-e4e8-4fb1-9635-901dc9446235	iloperidone 8 MG Oral Tablet [PSN] · iloperidone 8 MG Oral Tablet [SCD]	2	10	These highlights do not include all the information needed to use Iloperidone Tablets safely and effectively. See full prescribing information for Iloperidone Tablets. Iloperidone tablets, for oral use Initial U.S. Approval: 2009	20250313